Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

NCT01998217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Stone Disease

Interventions

DRUG: Remifentanil
DRUG: Flurbiprofen and remifentanil

Sponsor

Changhai Hospital